BRCA1 and ovarian cancer: There seems to be no increased risk of developing breast or ovarian in patients harbouring BRCA1/2 mutations through controlled ovarian stimulation, yet data in the literature is lacking regarding with paucity of studies looking at controlled ovarian stimulation in patients with ovarian cancer.